Document is current
Any future updates will be listed below
-
Authors
Xiao, Huimin
Cheng, Guiyun
Zhang, Haocheng
Liu, Yao
Chen, Zhongshao
Gao, Yuehan
Gao, Feng
Liu, Yanling
Wang, Shourong https://orcid.org/0000-0003-3394-1299
Kong, Beihua
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82072871)
Tai-Shan Scholar Program of Shandong Province (ts20070743)
Natural Science Foundation of Shandong Province (ZR2022QH286)
China Anti-Cancer Association - hengrui PARP inhibitors cancer research fund (CETSDHRCORP252-4-019)
- License Information
-
More Information
Article History
Received: 30 November 2024
Accepted: 13 April 2025
First Online: 30 April 2025
Declarations
:
: This study and included experimental procedures were approved by the institutional animal care and use committee of Qilu hospital of Shandong university (KYLL-202402-021). All animal housing and experiments were conducted in strict accordance with the institutional guidelines for care and use of laboratory animals.
: Not applicable.
: All authors have declared that no competing interest exists.
